MINGHAO LUO

Dr. MINGHAO LUO

Chongqing Medical University, Chongqing, China
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Aging and disease
Verified
Journal Article
Open access
PDF file
YGYongzheng Guo
Yongzheng Guo
CZCheng Zhang
Cheng Zhang
FSFei-Fei Shang
Fei-Fei Shang
MINGHAO LUOMINGHAO LUO
MINGHAO LUO
YYYuehua You
Yuehua You
LSLuo Suxin
Luo Suxin
The ketogenic diet (KD) has been widely used in clinical studies and shown to hace an anti-diabetic effect, but the underlying mechanisms have not been fully elaborated. Our aim was to investigate the effects and the underling mechanisms of the KD on cardiac function in db/db mice. In the present study, db/db mice were subjected to a normal diet (ND) or KD. Fasting blood glucose, cardiac function and morphology, mitochondrial dynamics, oxidative stress, and apoptosis were measured 8 weeks post KD treatment. Compared with the ND, the KD improved glycemic control and protected against diabetic cardiomyopathy in db/db mice, and improved mitochondrial function, as well as reduced oxidative stress were observed in hearts. In addition, KD treatment exerted an anti-apoptotic effect in the heart of db/db mice. Further data showed that the PI3K/Akt pathway was involved in this protective effect. Our data demonstrated that KD treatment ameliorates cardiac dysfunction by inhibiting apoptosis via activating the PI3K-Akt pathway in type 2 diabetic mice, suggesting that the KD is a promising lifestyle intervention to protect against diabetic cardiomyopathy.

1 April 2020 in Inflammation
Verified
Journal Article
Closed access
PDF file
MINGHAO LUOMINGHAO LUO
MINGHAO LUO
JMJiayu Meng
Jiayu Meng
JYJianghong Yan
Jianghong Yan
FSFeifei Shang
Feifei Shang
TZTing Zhang
Ting Zhang
SLSu Xin Luo
Su Xin Luo

21 February 2022 in International Immunopharmacology
Verified
Journal Article
Closed access
HYHuilin Yu
Huilin Yu
QLQian Liu
Qian Liu
GCGuodong Chen
Guodong Chen
LHLongxiang Huang
Longxiang Huang
MINGHAO LUOMINGHAO LUO
MINGHAO LUO
SLSuxin Luo
Suxin Luo

1 August 2020 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
YYYuehua You
Yuehua You
WTWanying Tan
Wanying Tan
YGYongzheng Guo
Yongzheng Guo
MINGHAO LUOMINGHAO LUO
MINGHAO LUO
FSFei-Fei Shang
Fei-Fei Shang
SLSuxin Luo
Suxin Luo
Progesterone exerts antihypertensive actions partially by modulating endothelial nitric oxide synthase (eNOS) activity. Here, we aimed to investigate the effects and mechanisms of progesterone on eNOS expression. First, human umbilical vein endothelial cells (HUVECs) were exposed to progesterone and then the eNOS transcription factor specificity protein-1 (SP-1) and progesterone receptor (PRA/B) expression were assessed by Western blotting and qRT-PCR. The interaction between SP-1 and PRA/B was next determined through coimmunoprecipitation assay. The chromatin immunoprecipitation assay and luciferase assay were used to investigate the relationship of PRA/B, SP-1, and eNOS promoter. At last, rats were intraperitoneally injected with progesterone receptor antagonist RU-486, and then the expression of eNOS and vasodilation function in thoracic aorta and mesenteric artery were measured. The results showed that progesterone could increase eNOS expression in HUVECs. Further study showed that progesterone increased PRA-SP-1 complex formation and facilitated PRA/B and SP-1 binding to eNOS promoter. Mutating SP-1 or PR-binding motif on eNOS promoter abolished the effect of progesterone on eNOS gene transcription. We also observed that progesterone receptor antagonist RU-486 reduced eNOS expression and impaired vasodilation in rats. Those results suggest that progesterone modulates eNOS expression through promoting PRA-SP-1 complex formation, and progesterone antagonist attenuates eNOS expression, leading to the loss of vascular relaxation. NEW & NOTEWORTHY Progesterone directly upregulated endothelial nitric oxide synthase (eNOS) expression in human endothelial cells. Progesterone augmented eNOS promoter activity through a progesterone receptor A- and specificity protein-1-dependent manner. Antagonism of the progesterone receptor reduced eNOS expression and impaired vasodilation in rats.

26 March 2021 in Inflammation
Verified
Journal Article
Closed access
PDF file
DLDingyi Lv
Dingyi Lv
MINGHAO LUOMINGHAO LUO
MINGHAO LUO
JYJianghong Yan
Jianghong Yan
XYXiyang Yang
Xiyang Yang
SLSu Xin Luo
Su Xin Luo

31 July 2021 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
MINGHAO LUOMINGHAO LUO
MINGHAO LUO
CCChunmei Cao
Chunmei Cao
JNJosef Niebauer
Josef Niebauer
JYJianghong Yan
Jianghong Yan
XMXindong Ma
Xindong Ma
GLGuochun Liu
Guochun Liu
We aimed to study the effects and underlying mechanism of different intensities of continuous training (CT) on vascular inflammation and oxidative stress in spontaneously hypertensive rats (SHR). Rats were divided into five groups (n = 12): Wistar‐Kyoto rats sedentary group (WKY‐S), sedentary group (SHR‐S), low‐intensity CT group (SHR‐L), medium‐intensity CT group (SHR‐M) and high‐intensity CT group (SHR‐H). Changes in body mass, heart rate and blood pressure were recorded. The rats were euthanized after 14 weeks, and blood and vascular tissue samples were collected. Haematoxylin and Eosin staining was used to observe the aortic morphology, and Western blot was used to detect the expression of mesenteric artery proteins. After CT, the mean arterial pressures improved in SHR‐L and SHR‐M and increased in SHR‐H compared with those in SHR‐S. Vascular inflammation and oxidative stress levels significantly subsided in SHR‐L and SHR‐M (p < 0.05), whereas in SHR‐H, only vascular inflammation significantly subsided (p < 0.05), and oxidative stress remained unchanged (p > 0.05). AMPK and SIRT1/3 expressions in SHR‐L and SHR‐M were significantly up‐regulated than those in SHR‐S (p < 0.05). These results indicated that low‐ and medium‐intensity CT can effectively reduce the inflammatory response and oxidative stress of SHR vascular tissue, and high‐intensity CT can improve vascular tissue inflammation but not oxidative stress.